Kidney growth in normal and diabetic mice is not affected by human insulin-like growth factor binding protein-1 administration

Experimental Biology and Medicine

Volumn 230, Issue 2, 2005, Pages 135-143

  Cingel Ristić, Vesna ^a   Schrijvers, Bieke F ^b   Van Vliet, Arlène K ^a   Rasch, Ruth ^c   Han, Victor K M ^d   Drop, Stenvert L S ^a   Flyvbjerg, Allan ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Diabetes; Growth hormone; Insulin like growth factor binding protein 1; Insulin like growth factor I; Mouse

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; KIDNEY HYPERTROPHY; KIDNEY MASS; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PROTEIN BINDING; PROTEIN CONTENT; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; PROTEINURIA; STREPTOZOCIN DIABETES;

ANIMALIA;

EID: 12744262832     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020523000208     Document Type: Article

References (24)

1. Hovind P, Tamow L, Rossing K, Rossing P, Eising S, Larsen N, Binder C, Parving HH. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26:1258-1264, 2003.
2. Flyvbjerg A. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes. Kidney Int Suppl 60:S12-S19, 1997.
3. Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev 22:53-74, 2001.
4. Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854, 2002.
5. Flyvbjerg A, Thorlacius-Ussing O, Naeraa R, Ingerslev J, Ørskov H. Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31:310-314, 1988.
6. Flyvbjerg A, Bornfeldt KE, Marshall SM, Arnqvist HJ, Ørskov H. Kidney IGF-I mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 33:334-338, 1990.
7. Flyvbjerg A, Ørskov H. Kidney tissue insulin-like growth factor I and initial renal growth in diabetic rats: relation to severity of diabetes. Acta Endocrinol (Copenh) 122:374-378, 1990.
8. Kobayashi S, Clemmons DR, Venkatachalam MA. Colocalization of insulin-like growth factor-binding protein with insulin-like growth factor I. Am J Physiol 261:F22-F28, 1991.
9. Landau D, Chin E, Bondy C, Domene H, Roberts CT Jr, Gronbaek H, Flyvbjerg A, LeRoith D. Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology 136:1835-1842, 1995.
10. van Buul-Offers SC, van Kleffens M, Koster JG, Lindenbergh-Kortleve DJ, Gresnigt MG, Drop SL, Hoogerbrugge CM, Bloemen RJ, Koedam JA, Van Neck JW. Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in Snell dwarf mice. Endocrinology 141:1493-1499, 2000.
11. Cingel-Ristić V, Van Neck JW, Frystyk J, Drop SLS, Flyvbjerg A. Administration of hIGFBP-1 increases circulating levels of growth hormone in mice. Endocrinology 145:4401-4407, 2004.
12. Flyvbjerg A, Bennett WF, Rasch R, Kopchick JJ, Scarlett JA. Inhibitory effect of a growth hormone receptor antagonist (G120K-PEG) on renal enlargement, glomerular hypertrophy, and urinary albumin excretion in experimental diabetes in mice. Diabetes 48:377-382, 1999.
13. Flyvbjerg A, Kessler U, Dorka B, Funk B, Ørskov H, Kiess W. Transient increase in renal insulin-like growth factor binding proteins during initial kidney hypertrophy in experimental diabetes in rats. Diabetologia 35:589-593, 1992.
14. Hill DJ, Clemmons DR, Riley SC, Bassett N, Challis JR. Immunohistochemical localization of insulin-like growth factors (IGFs) and IGF binding proteins -1, -2 and -3 in human placenta and fetal membranes. Placenta 14:1-12, 1993.
15. Segev Y, Landau D, Marbach M, Shehadeh N, Flyvbjerg A, Phillip M. Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor I. J Am Soc Nephrol 8:436-444, 1997.
16. Segev Y, Landau D, Rasch R, Flyvbjerg A, Phillip M. Growth hormone receptor antagonism prevents early renal changes in nonobese diabetic mice. J Am Soc Nephrol 10:2374-2381, 1999.
17. Fervenza FC, Tsao T, Hoffman AR, Rabkin R. Regional changes in the intrarenal insulin-like growth factor-I axis in diabetes. Kidney Int 51:811-818, 1997.
18. Schrijvers BF, Rasch R, Tilton RG, Flyvbjerg A. High protein-induced glomerular hypertrophy is vascular endothelial growth factor-dependent. Kidney Int 61:1600-1604, 2002.
19. Landau D, Segev Y, Afargan M, Silbergeld A, Katchko L, Podshyvalov A, Phillip M. A novel somatostatin analogue prevents early renal complications in the nonobese diabetic mouse. Kidney Int 60:505-512, 2001.
20. Frost RA, Bereket A, Wilson TA, Wojnar MM, Lang CH, Gelato MC. Phosphorylation of insulin-like growth factor binding protein-1 in patients with insulin-dependent diabetes mellitus and severe trauma. J Clin Endocrinol Metab 78:1533-1535, 1994.
21. Jones JI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR. Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I. Proc Natl Acad Sci U S A 88:7481-7485, 1991.
22. Frystyk J, Grofte T, Skjærbæk C, Ørskov H. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. J Clin Endocrinol Metab 82:3124-3127, 1997.
23. Sakai K, D'Ercole AJ, Murphy LJ, Clemmons DR. Physiological differences in insulin-like growth factor binding protein-1 (IGFBP-1) phosphorylation in IGFBP-1 transgenic mice. Diabetes 50:32-38, 2001.
24. Crossey PA, Jones JS, Miell JP. Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 49:457-465, 2000.